JPRN-UMIN000015968招募中未知
Phase II trial of weekly Nab-Paclitaxel as second-line chemotherapy for unrecectable or recurrent advanced gastric cancer. - Phase II trial of weekly Nab-Paclitaxel as second-line chemotherapy for unrecectable or recurrent advanced gastric cancer.
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) With history of receiving paclitaxel treatment 2) With peripheral neuropathy greater than Grade2 3) With serious drug allergy 4) With infectious disease and febrile condition (over 38 centigrade) 5) With active double cancers excluding carcinoma in situ and/or prior cancer cured with longer than 5 year interval period 6) With brain metastasis 7) With severe diseases: infectious disease/ uncontrolled DM /poorly controlled hypertension/ myocardial infarction/liver failure/pneumonia or pulmonary fibrosis 8) pregnant or nursing female or male expecting pregnancy of partner 9) Psychological illness 10) Any other patients whom the physician in charge of the study judges to be unsuitable
研究者
相似试验
已完成
1 期
Phase I/II trial of weekly nab-paclitaxel as second- or third-line treatment in patients with advanced non-small-cell lung cancer(OLCSG1303)on-small Cell Lung CancerJPRN-UMIN000012404Okayama Lung Cancer Study Group (OLCSG)55
已完成
不适用
Phase 2 trial of weekly Nab paclitaxel for advanced gastric cancer patients with prior chemotherapyadvanced advanced for gastric cancer patients with prior chemotherapyJPRN-UMIN000013105Toho University Graduate School of Medicine25
已完成
2 期
Phase 2 trial of weekly Nab paclitaxel for advanced gastric cancer patients with prior chemotherapyAdvanced Gastric CancerJPRN-UMIN000011882Teikyo University School of Medicine21
招募中
2 期
Phese 2 trial of weekly nab-paclitaxel in combination with gemcitabine in patients with metastatic breast cancer who have failed prior chemotherapyMetastatic and Recurrenced Breast CancerJPRN-UMIN000009153Toho University Omori Medical Center20
招募中
2 期
Phese 2 trial of weekly nab-paclitaxel in combination with gemcitabine in partients with metastatic breast cancerJPRN-UMIN000006427Toho University Omori Medical Center40